Beta human chorionic gonadotropin levels in cul-de-sac blood of patients with ectopic pregnancies

Area of Science:

• Reproductive Endocrinology
• Clinical Chemistry
• Gynecologic Surgery

Background:

• Ectopic pregnancy diagnosis remains a clinical challenge, often requiring sensitive and specific biomarkers.
• Human chorionic gonadotropin (hCG) is a key hormone in pregnancy, but its utility in localized fluid analysis for ectopic pregnancy is under investigation.

Purpose of the Study:

• To investigate and compare human chorionic gonadotropin (hCG) levels in cul-de-sac fluid versus peripheral blood in patients with ectopic pregnancies.
• To assess the potential of cul-de-sac hCG measurements for improving the diagnostic sensitivity of ectopic pregnancies.

Main Methods:

• Collection and analysis of both cul-de-sac and peripheral blood samples from patients diagnosed with ectopic pregnancy.
• Quantification of hCG levels using radioimmunoassay (RIA).
• Inclusion of protease inhibitors (aprotinin, phenylmethylsulfony fluoride) and Con-A chromatography to rule out enzymatic interference in RIA results from cul-de-sac samples.

Main Results:

• Significantly higher hCG concentrations were observed in cul-de-sac blood compared to peripheral blood (P < 0.01).
• Protease inhibitors and Con-A chromatography confirmed that proteolytic enzymes did not interfere with RIA results from cul-de-sac samples.
• The observed elevation of hCG in cul-de-sac blood is a genuine finding, not an artifact of sample degradation.

Conclusions:

• Cul-de-sac fluid exhibits markedly elevated levels of hCG in ectopic pregnancies.
• Assaying hCG in cul-de-sac blood offers a promising approach to enhance the sensitivity and accuracy of ectopic pregnancy diagnosis.
• This localized biomarker measurement could potentially lead to earlier and more reliable detection of ectopic pregnancies.